Maynard Um
-
-
-
-
-
-
-
Exagen (XGN) PT Lowered to $9 at BTIG
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Exagen (XGN)
-
-
-
-
-
-
-
Exagen Inc. (XGN) Misses Q2 EPS by 6c
-
-
-
-
-
-
-
KeyBanc Reiterates Sector Weight Rating on Exagen (XGN)
-
-
-
-
-
-
-
Exagen Inc (XGN) Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE CTD Platform
-
-
-
-
-
404,878 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

